Law

The Misuse of Drugs (Amendment No. 3) (England, Wales and Scotland) Regulations 2014

United Kingdom · regulation

Ask the law about this More laws of United Kingdom For machines: Markdown

In force since 2015-01-07, as the publisher states.

Copy read on 2026-11-10. The page it was read from

Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

sha256 ad0fa653029eb1e45f06ef7b24e5f8fed655dfb085f612420a592eb104ca53fb

Contents: 7 provisions

Proposed changes to this act

No one has proposed a change to this act yet.

7 provisions

Title and introductory text

2014 No. 3277 Dangerous Drugs, England And Wales Dangerous Drugs, Scotland The Misuse of Drugs (Amendment No. 3) (England, Wales and Scotland) Regulations 2014 Made 11th December 2014 Laid before Parliament 17th December 2014 Coming into force 7th January 2015 The Secretary of State makes the following Regulations in exercise of the powers conferred by sections 7, 10, 22 and 31 of the Misuse of Drugs Act 1971. In accordance with section 31(3) of that Act the Secretary of State has consulted with the Advisory Council on the Misuse of Drugs.

Propose a change

1 Citation, commencement and extent

(1) These Regulations may be cited as the Misuse of Drugs (Amendment No. 3) (England, Wales and Scotland) Regulations 2014 and come into force on 7th January 2015. (2) These Regulations extend to England and Wales and Scotland.

Propose a change

2 Amendment of the Misuse of Drugs Regulations 2001

The Misuse of Drugs Regulations 2001 are amended as follows.

Propose a change

3 Amendment of the Misuse of Drugs Regulations 2001

In paragraph 1(a) of Schedule 1 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27)— (a) after “Tenocyclidine” insert— (6aR,9R)-4-acetyl-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (ALD-52) ; (b) after “4-bromo-2,5-dimethoxy-a-methylphenethylamine” insert— 3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921) (6aR,9R)-N,N-diethyl-7-allyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (AL-LAD) (6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (ETH-LAD) (6aR,9R)-N,N-diethyl-7-propyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (PRO-LAD) ; (c) after “2-((Dimethylamino)methyl)-1-(3-hydroxyphenyl)cyclohexanol” insert— 2,4-dimethylazetidinyl{(6aR,9R)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinolin-9-yl}methanone (LSZ) .

Propose a change

4 Amendment of the Misuse of Drugs Regulations 2001

For paragraph 1(b) of Schedule 1, substitute— (b) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by modification in any of the following ways, that is to say— (i) by substitution at the nitrogen atom of the sidechain to any extent with alkyl or alkenyl substituents, or by inclusion of the nitrogen atom of the side chain (and no other atoms of the side chain) in a cyclic structure; (ii) by substitution at the carbon atom adjacent to the nitrogen atom of the side chain with alkyl or alkenyl substituents; (iii) by substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, thioalkyl, alkylenedioxy, or halide substituents; (iv) by substitution at the 2-position of the tryptamine ring system with an alkyl substituent; .

Propose a change

5 Amendment of the Misuse of Drugs Regulations 2001

In Schedule 2 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 21, 23, 26 and 27) after “Hydropmorphone” insert— 4-Hydroxy-n-butyric acid .

Propose a change

6 Amendment of the Misuse of Drugs Regulations 2001

In paragraph 1 of Part 1 of Schedule 4 (which specifies controlled drugs subject to the requirements of regulations 22, 23, 26 and 27) omit “4-Hydroxy-n-butyric acid”.

Propose a change

← Find another law